Literature DB >> 10508784

The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.

H Blanchard1, L Kodandapani, P R Mittl, S D Marco, J F Krebs, J C Wu, K J Tomaselli, M G Grütter.   

Abstract

BACKGROUND: In the initial stages of Fas-mediated apoptosis the cysteine protease caspase-8 is recruited to the cell receptor as a zymogen (procaspase-8) and is incorporated into the death-signalling complex. Procaspase-8 is subsequently activated leading to a cascade of proteolytic events, one of them being the activation of caspase-3, and ultimately resulting in cell destruction. Variations in the substrate specificity of different caspases have been reported.
RESULTS: We report here the crystal structure of a complex of the activated human caspase-8 (proteolytic domain) with the irreversible peptidic inhibitor Z-Glu-Val-Asp-dichloromethylketone at 2.8 A resolution. This is the first structure of a representative of the long prodomain initiator caspases and of the group III substrate specificity class. The overall protein architecture resembles the caspase-1 and caspase-3 folds, but shows distinct structural differences in regions forming the active site. In particular, differences observed in subsites S(3), S(4) and the loops involved in inhibitor interactions explain the preference of caspase-8 for substrates with the sequence (Leu/Val)-Glu-X-Asp.
CONCLUSIONS: The structural differences could be correlated with the observed substrate specificities of caspase-1, caspase-3 and caspase-8, as determined from kinetic experiments. This information will help us to understand the role of the various caspases in the propagation of the apoptotic signal. The information gained from this investigation should be useful for the design of specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508784     DOI: 10.1016/s0969-2126(99)80179-8

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  35 in total

1.  The structure of procaspase 6 is similar to that of active mature caspase 6.

Authors:  Byoung Heon Kang; Eunsil Ko; Oh-Keun Kwon; Kwan Yong Choi
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

Review 2.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

Review 3.  Caspases: pharmacological manipulation of cell death.

Authors:  Inna N Lavrik; Alexander Golks; Peter H Krammer
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 4.  Structural basis of signal transduction in the TNF receptor superfamily.

Authors:  Jixi Li; Qian Yin; Hao Wu
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

5.  Structural basis for the activation of human procaspase-7.

Authors:  S J Riedl; P Fuentes-Prior; M Renatus; N Kairies; S Krapp; R Huber; G S Salvesen; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 6.  Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate.

Authors:  Bram J van Raam; Guy S Salvesen
Journal:  Biochim Biophys Acta       Date:  2011-06-16

Review 7.  Proteases for cell suicide: functions and regulation of caspases.

Authors:  H Y Chang; X Yang
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 8.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

9.  Role of loop bundle hydrogen bonds in the maturation and activity of (Pro)caspase-3.

Authors:  Brett Feeney; Cristina Pop; Paul Swartz; Carla Mattos; A Clay Clark
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

10.  Caspase-mediated processing of the Drosophila NF-kappaB factor Relish.

Authors:  Svenja Stoven; Neal Silverman; Anna Junell; Marika Hedengren-Olcott; Deniz Erturk; Ylva Engstrom; Tom Maniatis; Dan Hultmark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.